Tin tức & Cập nhật

Lower-sodium oxybate – a new oxybate treatment with 92-percent less sodium than sodium oxybate – continued to demonstrate its potential in improving function, productivity, and sleepiness in individuals with idiopathic hypersomnia, according to data presented at AAN 2022.

New drug applications approved by US FDA as of 16-30 April 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A novel wearable device can accurately measure range of motion (ROM) and gait in patients who had undergone total knee replacement (TKR), according to a recent study. This proposed system could facilitate portable progress monitoring in this population.

Viên nén phóng thích kéo dài chứa mirabegron 25 mg và 50 mg

There are no COVID-19 cases documented in patients with solid tumours at 1-year post-vaccination with the BNT162b2 vaccine as shown in a prospective study from Israel.